Which Semaglutide Is Approved for Weight Loss? Approved Brands and Products
FDA approved semaglutide which is a medication used to treat obesity and manage weight. It is an incretin mimetic that stimulates the GLP-1 receptor, with resultant feeling of satiety, delayed gastric emptying and reduced appetite. It has been shown that semaglutide can help people lose weight when they are used together with exercise and diet.
Branded products have been authorized
Presently, there are two brands of semaglutide for weight loss; Wegovy and Ozempic. Wegovy is an enhanced dose of semaglutide meant for managing obesity while Ozempic is a low dose of this product mainly applied in type 2 diabetes management.
Wegovy is indicated for use in combination with a reduced calorie meal plan along with increased physical activity in adults who have BMIs of either 30 kg/m^2or more or 27kg/m^2 or higher plus at least one weight-related co-morbid condition like hypertension, high cholesterol levels or type 2 diabetes. Once-weekly dosing via subcutaneous injection.
Ozempic can be prescribed to adult patients suffering from type II diabetes mellitus whose blood glucose level cannot be controlled by diet alone or other oral antidiabetic medications, but it has also been seen to cause weight reduction among some individuals using it. Subcutaneous once weekly injection.
Side effects
Both Wegovy and Ozempic may result in certain side effects such as nausea, vomiting, diarrhea, constipation, abdominal pain and decreased appetite. These side effects usually disappear on their own after the body accommodates the drug but if they become severe or persistent then a healthcare provider needs to be consulted upon.
Pancreatitis (inflammation of the pancreas), kidney impairment leading to kidney failure (kidney damage) and thyroid tumors have been associated with semaglutide use according to some reports. Therefore, relevant caregivers should closely follow-up their patients on semaglutide for early detection of complications.
Semaglutide should not be given to pregnant or breastfeeding mothers since it may cause harm to the fetus or newborns. Also, if a patient has suffered from pancreatitis in the past or has multiple endocrine neoplasia syndrome type 2 (MEN2), he/she should not take semaglutide because it may exacerbate the existing situation.
Medicine costs
The expense of Wegovy and Ozempic is very high; they go above a hundred dollars per month. Nonetheless, majority of health insurance policies do cover these drugs such as those with BMIs greater than 30 or patients with type 2 diabetes mellitus.
However, individuals who lack coverage for such treatment by their payers can inquire about financial support programs available at drug companies like Novo Nordisk. These offers assist in minimizing the cost burden for such drugs and thus making them affordable to those truly deserving them.
Summary
In conclusion, semaglutide represents a new hope for people struggling with weight gain due to obesity. Both Wegovy and Ozempic proved successful in reducing weight thereby facilitating the achievement of weight management goals among patients as part of an overall strategy entailing diet program and physical activities.
If you decide that you want your doctor to prescribe semaglutide for you so that you could lose weight then consult your healthcare provider first. They will help you make sure whether semaglutide is appropriate regarding your personal needs but also advise on how to use this medicine properly and efficiently.
side effects of semaglutide injections for weight loss
semaglutide vs mounjaro for weight loss
semaglutide weight loss review
does unitedhealthcare cover semaglutide for weight loss
semaglutide vs mounjaro for weight loss